These drugs have caused a revolution in the diabetes and weight loss arenas not only due to their success, but also because of their cost
Patients interested in learning more can also explore our Weight Loss Treatments page for additional information about semaglutide, tirzepatide, and medically supervised care
Naturally occurring compounds like BPC-157 cannot be patented, reducing pharmaceutical industry incentive to fund expensive trials
Choosing the Right Agent: A Review of the Evidence from CVOTs The market for both GLP-1 receptor agonists and SGLT2 inhibitors has expanded significantly
2019;21(Suppl 1):3-16
5.4 Use in Women of Childbearing Potential Because of the risk to the fetus of decreased IQ, neurodevelopmental disorders, and major congenital malformations (including neural tube defects), which may occur very early in pregnancy, valproate should not be administered to a woman of childbearing potential unless other medications have failed to provide adequate symptom control or are otherwise unacceptable
